These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30564897)

  • 1. Oxime K203: a drug candidate for the treatment of tabun intoxication.
    Gorecki L; Soukup O; Kucera T; Malinak D; Jun D; Kuca K; Musilek K; Korabecny J
    Arch Toxicol; 2019 Mar; 93(3):673-691. PubMed ID: 30564897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oxime k203 as antidote in tabun poisoning.
    Kovarik Z; Vrdoljak AL; Berend S; Katalinić M; Kuc K; Musilek K; Radić B
    Arh Hig Rada Toksikol; 2009 Mar; 60(1):19-26. PubMed ID: 19329372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
    Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Musilek K; Horova A
    Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Musilek K; Horova A
    Toxicol Mech Methods; 2013 Feb; 23(2):94-8. PubMed ID: 22901042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase.
    Kuca K; Musilek K; Jun D; Zdarova-Karasova J; Nepovimova E; Soukup O; Hrabinova M; Mikler J; Franca TCC; Da Cunha EFF; De Castro AA; Valis M; Ramalho TC
    BMC Pharmacol Toxicol; 2018 Feb; 19(1):8. PubMed ID: 29467029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
    Lo R; Ganguly B
    Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
    Kassa J; Humlicek V
    Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of neuroprotective efficacy of two novel reactivators of acetylcholinesterase called K920 and K923 with the oxime K203 and trimedoxime in tabun-poisoned rats.
    Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J
    Toxicol Mech Methods; 2017 Mar; 27(3):236-243. PubMed ID: 28043192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
    Ghosh S; Chandar NB; Jana K; Ganguly B
    J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in Mice.
    Kassa J; Timperley CM; Bird M; Williams RL; Green AC; Tattersall JEH
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):429-435. PubMed ID: 29117635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
    Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.